For CDx developers, liquid biopsy companies, central labs and FDA regulatory consultancies: pre-scheduled 1:1 meetings with the pharma teams choosing co-development partners.
Sponsor San Diego 2027
Our sponsorship team replies within one working day.
Trusted by sponsors from our London 2026 launch edition

ImmunoMark San Diego is a companion diagnostics conference in San Diego built around one commercial question: which diagnostics partner does a drug program choose, and when? The launch edition’s prospectus tagline says it plainly: “Driving the Future of Companion Diagnostics from Discovery to Commercial Adoption”.
For a CDx developer, liquid biopsy company, central lab or FDA regulatory consultancy, that is a partnering brief, not a booth-traffic brief. A US companion diagnostic is normally expected to reach approval at the same time as its therapy, usually through a PMA, which means pharma teams lock in diagnostics partners long before pivotal trials read out. The window to be considered is early and narrow.
The rules around lab-developed tests have also shifted. After a federal court vacated the FDA’s LDT rule in March 2025, pharma teams are again weighing central-lab, LDT-based approaches against kit-based CDx strategies program by program. That makes 2027 a year when both kit manufacturers and lab service providers have something new to say to the same buyers.
The San Diego speaker faculty is a good map of the pharma functions involved in a CDx decision. Each one asks a different question of a diagnostics partner.
| Role on the San Diego faculty | What they are evaluating in a partner |
|---|---|
| Global Director of Regulatory Affairs (Precision Medicine), Gilead Sciences | Your FDA submission track record, bridging study experience and readiness for contemporaneous approval |
| Senior Director, Precision Medicine Strategy, Regeneron | Platform fit for the biomarker, global test availability and how your timelines line up with the clinical plan |
| Director, Biomarker and Translational Sciences, Johnson & Johnson | Analytical validation and the path from clinical trial assay to final CDx |
| U.S. Market Access Strategy Lead, AstraZeneca | Coverage, reimbursement and whether patients can actually get the test after launch |
| Director, Digital Pathology and Image Analysis Group, Pfizer | Scoring reproducibility and validation of image-based and algorithm-assisted readouts |
Speakers are a guide to the functions in the room, not a list of guaranteed meetings. Your 1:1 meetings are chosen from the full delegate list, which lets you target these functions across every company that comes.
Stream 2 covers the full CDx lifecycle, from predictive biomarker evidence to regulation and reimbursement. These sessions put your buyers in the right frame of mind before they meet you.
For liquid biopsy companies, the MRD session makes this a practical liquid biopsy conference in San Diego without a separate event; the liquid biopsy and spatial sponsor page compares that content across editions. Because the program runs from biomarker evidence to adoption, it also works as a translational oncology conference in San Diego for teams that sell both assay development and clinical testing. For a refresher on the US pathway your buyers will be discussing, see our step-by-step guide to FDA companion diagnostic approval.
Pre-scheduled meetings are the core of a CDx sponsorship. Here is how to run them for a partnering audience.
Estimate what a set of CDx partnering meetings is worth to your pipeline.
Run the ROI calculatorAt a diagnostics conference in San Diego focused on partnering, the right package is the one that gets you the most qualified meetings for your stage of relationship.
Meetings without the overhead. Ideal for regulatory consultancies, central labs and CDx teams whose business is won across a table, not a booth.
For CDx developers with a co-development story to tell from the stage before the market access and partnership sessions.
A Day 2 talk on the day clinical utility and global regulatory strategy are discussed.
Every tier includes the delegate list with contact details and post-event branding. Full details are on the San Diego sponsorship opportunities page. If your buyers sit in Europe and IVDR or MHRA is the conversation, see the London companion diagnostics page. If you sell sequencing or data into the same programs, the San Diego precision medicine page is the better fit.
Tell us your target functions and we will suggest a meeting package.
Request the prospectusPick a package, add your own numbers and see the pipeline it creates. London 2026 sponsors averaged 15 to 25 meetings each, with 70% senior decision-makers in the room.
1. Choose a package
2. Your numbers
Year-one value of a new pharma or biotech customer
Booth visits, networking and questions after your talk
Share of conversations worth a proposal
Your typical close rate
Sponsorship plus travel and team costs
expected first-year revenue for every $1 of your event budget
Estimates only, based on the numbers you enter. Meetings and inclusions from the San Diego 2027 sponsorship prospectus. 1:1 meetings are pre-scheduled with delegates you choose from the attendee list.
What sponsors said
Here is what sponsors told us at our London 2026 launch edition.
We really liked the focus of the event, the topics, the talks, really good opportunity to engage with people, the support we get from you is really great and we appreciate that very much. Based on our experience we would be very interested in also sponsoring the next annual event.

We are always interested in sponsoring interesting conference, based on this years experience, I guess I will manage to get some budget for the next edition.

Conversations I have had are very high level, the footfalls been great and the kind of research going on around is really life changing. We will be very interested in sponsoring the second annual.

My experience here at Immunomark 2026 has been really great. We benefit from very good logistical organisation. Networking sessions were excellent and we consider Immunomark a strategic conference for the coming years.

We got the occasion to discuss customer projects and understand their needs better and how we can help them.

The conference has been great so far with strong interactions at the booth and excellent attendance at our talk. We will definitely think about the next edition.

Quality of the talks were really nice and the attendee list had experts from biotech pharma field. It was great meeting everyone and we look forward to positive outcomes.

The talks have been really interesting so far with a great combination of researchers and clinicians. Moderators encouraged excellent discussions.

Yes. Stream 2 covers the whole CDx lifecycle, including clinical utility, market access and global regulatory strategy, and the delegate profile is weighted to biotech and pharma (55–60%) with 45–50% senior leadership. Central labs use 1:1 meetings to reach the translational and precision medicine teams who decide how trial testing is run.
Day 2 of Stream 2 includes Global Regulatory Strategies for Companion Diagnostics and Precision Medicine, and Day 1 includes Market Access and Reimbursement Strategies for Companion Diagnostics in Precision Oncology. The speaker faculty includes Gilead Sciences' Global Director of Regulatory Affairs (Precision Medicine).
You choose from the full delegate list and profiles, sent 10 days before the event, and can flag priorities with the wishlist feature. Meetings are 20 minutes each and pre-scheduled, so you can build your two days around specific pharma functions.
San Diego (10–11 February 2027) is the US launch edition, where FDA approval, US market access and the US lab landscape frame the conversation. London (3–4 March 2027) is the 2nd annual edition, with 60% of delegates from the UK and Ireland and 40% from the rest of Europe, and its agenda includes a panel on EMA, FDA and MHRA CDx approval pathways.
Speaking slots come with Platinum, Gold and Silver, and each of those includes a 10 x 6 ft booth. If you want meetings without a booth or talk, the Exclusive 1:1 Meetings packages (3, 5, 7 or 10 meetings) are designed for that.
Tell us who you want to meet. We will send the prospectus, current package availability and a recommendation within one working day.